United States · Bill · HR
H.R. 1031 (100th)
Prescription Drug Marketing Act of 1987
Introduced
5 February 1987
Last action
22 April 1988 · Committee
Status
See H.R.1207.
Sponsors
Rep. Dingell, John D. [D-MI-12], Rep. Lent, Norman F. [R-NY-4], Rep. Florio, James J. [D-NJ-1], Rep. Luken, Thomas A. [D-OH-1], Rep. Walgren, Doug [D-PA-18], Rep. Oxley, Michael G. [R-OH-4], Rep. Leland, Mickey [D-TX-18], Rep. Tauzin, W. J. (Billy) [R-LA-3], Sen. Wyden, Ron [D-OR], Rep. Hall, Tony P. [D-OH-3], Rep. Eckart, Dennis E. [D-OH-11], Rep. Slattery, Jim [D-KS-2], Rep. Bryant, John W. [D-TX-5], Rep. Boucher, Rick [D-VA-9], Rep. Cooper, Jim [D-TN-5]
Subjects
Healthcare
Source updated
3 June 2026
Summary
Prescription Drug Marketing Act of 1987 - Amends the Federal Food, Drug, and Cosmetic Act to permit only the U.S. manufacturer of a drug to reimport such drug into the United States. Prohibits the sale of prescription drug samples. Permits the distribution of samples only to practitioners licensed to prescribe such drugs. Requires the Secretary of Health and Human Services to issue guidelines for sample request forms. Requires such practitioners to return a receipt for such drug samples to the manufacturers to be kept and made available to Federal and State officials. Requires drug wholesalers to provide drug purchasers with a statement identifying the manufacturer and each sale of the drug. Directs the Secretary to issue licensing standards for drug wholesalers. Sets forth criminal penalties for violations of this Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 February 1987
Introduced
Referred to House Committee on Energy and Commerce.
Source: IntroReferral
5 February 1987
Introduced
Introduced in House
Source: IntroReferral
5 February 1987
Introduced
Introduced in House
Source: IntroReferral
19 February 1987
Referred
Referred to Subcommittee on Health and the Environment.
Source: Committee
22 April 1988
Committee
See H.R.1207.
Source: Committee
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 5 February 1987
Sponsors
- Rep. Dingell, John D. [D-MI-12] · D · Sponsor
- Rep. Lent, Norman F. [R-NY-4] · R · Sponsor
- Rep. Florio, James J. [D-NJ-1] · D · Sponsor
- Rep. Luken, Thomas A. [D-OH-1] · D · Sponsor
- Rep. Walgren, Doug [D-PA-18] · D · Sponsor
- Rep. Oxley, Michael G. [R-OH-4] · R · Sponsor
- Rep. Leland, Mickey [D-TX-18] · D · Sponsor
- Rep. Tauzin, W. J. (Billy) [R-LA-3] · D · Sponsor
- Sen. Wyden, Ron [D-OR] · D · Sponsor
- Rep. Hall, Tony P. [D-OH-3] · D · Sponsor
- Rep. Eckart, Dennis E. [D-OH-11] · D · Sponsor
- Rep. Slattery, Jim [D-KS-2] · D · Sponsor
- Rep. Bryant, John W. [D-TX-5] · D · Sponsor
- Rep. Boucher, Rick [D-VA-9] · D · Sponsor
- Rep. Cooper, Jim [D-TN-5] · D · Sponsor
- · hsif00 · Standing
Related records
- related to ← Prescription Drug Marketing Act of 1987
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/100th-congress/house-bill/1031
- Open data entity: https://api.congress.gov/v3/bill/100/hr/1031
- us · 100-hr-1031 · source updated 3 June 2026